Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[b]furan

7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[b]furan Structure
  • ₹0
  • Product name: 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[b]furan
  • CAS: 1192755-14-8
  • MF: C14H17BO3
  • MW: 244.09
  • EINECS:
  • MDL Number:MFCD13810042
  • Synonyms:7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[b]furan;Benzofuran-7-boronic acid pinacol ester;7-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzofuran;2-(1-benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-(Benzofuran-7-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;Benzofuran-7-boronic acid picol ester;Benzofuran, 7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

storage temp. :Sealed in dry,Store in freezer, under -20°C

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H302 Harmful if swallowed Acute toxicity,oral Category 4 Warning GHS hazard pictograms P264, P270, P301+P312, P330, P501
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation Specific target organ toxicity, single exposure;Respiratory tract irritation Category 3 Warning GHS hazard pictograms
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Description

Benzofuran-7-boronic Acid Pinacol Ester acts as a reagent in the preparation of 5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group for the treatment of hyper-proliferative disorders.